Olema Pharmaceuticals added new hires to advance its oncology strategy, signaling continued investment in cancer R&D and patient outcomes as biotech competition

Olema Pharmaceuticals added new hires to advance its oncology strategy, signaling continued investment in cancer R&D and patient outcomes as biotech competition intensifies. The push follows last year’s market-access appointment and broader hiring campaign.